Understanding a Mutant that Disregulates Trehalose 6-Phosphate Action in Plants

了解破坏植物中海藻糖 6-磷酸作用的突变体

基本信息

  • 批准号:
    BB/T016329/1
  • 负责人:
  • 金额:
    $ 101.75万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2020
  • 资助国家:
    英国
  • 起止时间:
    2020 至 无数据
  • 项目状态:
    未结题

项目摘要

Sucrose formed in photosynthesis is the starting point for the synthesis of all plant products including those involved in growth and development, the harvested organs of crops, and the synthesis of starch, cell walls, proteins and lipids, which are the constituents of food, fibre, feed and fuel. Trehalose 6-phosphate (T6P) is a sugar signal, or sugar fuel gauge intimately involved with sucrose biology relaying information to cells about the availably of sucrose. Despite the indispensable importance of the T6P signalling system in plants and crops there are many unanswered questions about the mechanisms involved in regulating the accumulation of T6P. This has important implications as a science grand challenge i.e. the regulation of plant "blood sugar" and the basis of T6P's determination of overall growth, yield and resistance to abiotic and biotic stresses, and translation in the form of increased crop yields and crop resilience. To address the fundamental question of how plants regulate T6P accumulation and hence all these processes on which this depends, we bring together a unique collaboration of researchers in chemical biology and molecular plant science applying tools unrivalled in one consortium of molecular genetic, biochemical, chemical and multi omics to understand the role of specific trehalose phosphate synthases and a protein kinase and their interaction with each other, and with other proteins and ligands.
在光合作用中形成的蔗糖是合成所有植物产品的起点,包括参与生长和发育的植物产品、收获的作物器官以及淀粉、细胞壁、蛋白质和脂质的合成,这些是食物、纤维、饲料和燃料的成分。海藻糖6-磷酸(T6 P)是一种糖信号,或糖燃料测量仪,与蔗糖生物学密切相关,将有关蔗糖可用性的信息传递给细胞。尽管T6 P信号系统在植物和作物中具有不可或缺的重要性,但关于T6 P积累的调节机制仍有许多未解之谜。这具有重要的意义,作为一个科学的大挑战,即植物“血糖”的调节和T6 P的整体生长,产量和对非生物和生物胁迫的抗性的确定的基础,以及以增加作物产量和作物恢复力的形式的转化。为了解决植物如何调节T6 P积累的基本问题,以及因此所依赖的所有这些过程,我们汇集了化学生物学和分子植物科学研究人员的独特合作,应用分子遗传学,生物化学,化学和多组学联盟中无与伦比的工具,以了解特定海藻糖磷酸脱氢酶和蛋白激酶的作用及其相互作用,以及其他蛋白质和配体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Benjamin Davis其他文献

A lesion-mimic mutant of Catharanthus roseus accumulates the opioid agonist, akuammicine.
长春花的损伤模拟突变体会积累阿片类激动剂 akuammicine。
  • DOI:
    10.1016/j.phytochem.2022.113422
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Fanfan Li;S. Bordeleau;K. Kim;Jonathan Turcotte;Benjamin Davis;Lan Liu;S. Bayen;V. De Luca;Mehran Dastmalchi
  • 通讯作者:
    Mehran Dastmalchi
Enhancing User Performance by Adaptively Changing Haptic Feedback Cues in a Fitts's Law Task
通过在菲茨定律任务中自适应地改变触觉反馈线索来提高用户性能
  • DOI:
    10.1109/toh.2024.3358188
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Drake Rowland;Benjamin Davis;Taylor M. Higgins;A. M. Fey
  • 通讯作者:
    A. M. Fey
Pediatric eosinophilic gastritis treated with benralizumab: A case report
贝那利珠单抗治疗小儿嗜酸性粒细胞性胃炎:一例报告
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    D. Cheung;Dawn Ebach;Benjamin Davis
  • 通讯作者:
    Benjamin Davis
From the prodromal stage of multiple sclerosis to disease prevention
从多发性硬化的前驱期到疾病预防
  • DOI:
    10.1038/s41582-022-00686-x
  • 发表时间:
    2022-07-15
  • 期刊:
  • 影响因子:
    33.100
  • 作者:
    Ruth Ann Marrie;Mark Allegretta;Lisa F. Barcellos;Bruce Bebo;Peter A. Calabresi;Jorge Correale;Benjamin Davis;Philip L. De Jager;Christiane Gasperi;Carla Greenbaum;Anne Helme;Bernhard Hemmer;Pamela Kanellis;Walter Kostich;Douglas Landsman;Christine Lebrun-Frenay;Naila Makhani;Kassandra L. Munger;Darin T. Okuda;Daniel Ontaneda;Ronald B. Postuma;Jacqueline A. Quandt;Sharon Roman;Shiv Saidha;Maria Pia Sormani;Jon Strum;Pamela Valentine;Clare Walton;Kathleen M. Zackowski;Yinshan Zhao;Helen Tremlett
  • 通讯作者:
    Helen Tremlett
Rural Household Access to Assets and Markets: A Cross-Country Comparison
  • DOI:
    10.1057/ejdr.2011.15
  • 发表时间:
    2011-06-30
  • 期刊:
  • 影响因子:
    2.600
  • 作者:
    Alberto Zezza;Paul Winters;Benjamin Davis;Gero Carletto;Katia Covarrubias;Luca Tasciotti;Esteban Quiñones
  • 通讯作者:
    Esteban Quiñones

Benjamin Davis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Benjamin Davis', 18)}}的其他基金

ISOBIOTICS: Isotopic Labeling of Biotherapeutics
ISOBIOTICS:生物治疗药物的同位素标记
  • 批准号:
    EP/X039501/1
  • 财政年份:
    2023
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Research Grant
Exploring and Driving Cooperative International Strategies in Sustainable Chiral Pool Natural Product Synthesis
探索和推动可持续手性库天然产物合成的国际合作策略
  • 批准号:
    BB/W018705/1
  • 财政年份:
    2022
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Research Grant
Radical Radiochemistry for Site- and Copy-Controlled 18F-Labeling of Proteins
用于蛋白质位点和拷贝控制 18F 标记的自由基放射化学
  • 批准号:
    BB/V010999/1
  • 财政年份:
    2021
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Research Grant
Rosalind Franklin Institute - Next Generation Chemistry
罗莎琳德·富兰克林研究所 - 下一代化学
  • 批准号:
    EP/V011359/1
  • 财政年份:
    2020
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Research Grant
A High-throughput discovery facility for the Rosalind Franklin Institute
罗莎琳德·富兰克林研究所的高通量发现设施
  • 批准号:
    EP/V011367/1
  • 财政年份:
    2020
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Research Grant
Understanding and Exploiting Tunicamycin (Bio)Synthesis to Enable Novel Antibiotics and Inhibitors
了解和利用衣霉素(生物)合成来开发新型抗生素和抑制剂
  • 批准号:
    BB/J009725/1
  • 财政年份:
    2012
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Research Grant
Engineering stable calibration standards for biomedical research
为生物医学研究设计稳定的校准标准
  • 批准号:
    EP/I500200/1
  • 财政年份:
    2011
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Research Grant
The CHELL : A Bottom-Up approach to in vitro and in silico Minimal Life-like Constructs
CHELL:体外和计算机模拟最小类生命结构的自下而上方法
  • 批准号:
    EP/G026688/1
  • 财政年份:
    2009
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Research Grant
Creating a Synthetic Platform for Understanding and Exploiting Glycoconjugates
创建一个理解和利用糖复合物的合成平台
  • 批准号:
    EP/E000614/1
  • 财政年份:
    2007
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Research Grant
Dissecting the mechanism by which glycosyltransferases calalyse mannosyl transfer
剖析糖基转移酶催化甘露糖基转移的机制
  • 批准号:
    BB/E004350/1
  • 财政年份:
    2007
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Research Grant

相似海外基金

Low-grade diffusely infiltrative tumor, SMARCB1-mutantの分子生物学的特徴の解明
阐明 SMARCB1 突变低度弥漫浸润肿瘤的分子生物学特征
  • 批准号:
    24K10151
  • 财政年份:
    2024
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evaluating novel mutant-selective PDE4D PROTACs for the treatment of Acrodysostosis Type 2
评估新型突变选择性 PDE4D PROTAC 治疗 2 型肢节性骨质疏松症
  • 批准号:
    MR/Y003640/1
  • 财政年份:
    2024
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Research Grant
Investigating cell cycle vulnerabilities in TP53 mutant cancers
研究 TP53 突变癌症的细胞周期脆弱性
  • 批准号:
    MR/Y01264X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Research Grant
Structure-based identification of optimized mutant Kir3.4 inhibitors for renoprotection (C07 (A03 + A04))
基于结构的肾脏保护优化突变型 Kir3.4 抑制剂的鉴定 (C07 (A03 A04))
  • 批准号:
    516847250
  • 财政年份:
    2023
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Collaborative Research Centres
Therapeutic strategies targeting iron addiction in KRAS mutant refractory cancers
针对 KRAS 突变难治性癌症铁成瘾的治疗策略
  • 批准号:
    23H02611
  • 财政年份:
    2023
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Investigation of molecular mechanisms for overgrowth and aberrant hypermethylation using H19-ICR mutant mouse panel
使用 H19-ICR 突变小鼠组研究过度生长和异常高甲基化的分子机制
  • 批准号:
    23K05592
  • 财政年份:
    2023
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Collaborative Research: EDGE FGT: Genome-wide knock-out mutant libraries for the microcrustacean Daphnia
合作研究:EDGE FGT:微甲壳动物水蚤的全基因组敲除突变体文库
  • 批准号:
    2324639
  • 财政年份:
    2023
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Continuing Grant
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
  • 批准号:
    23K15297
  • 财政年份:
    2023
  • 资助金额:
    $ 101.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Targeting the mutant promoter of Telomerase Reverse Transcriptase (TERT)
靶向端粒酶逆转录酶 (TERT) 的突变启动子
  • 批准号:
    10677899
  • 财政年份:
    2023
  • 资助金额:
    $ 101.75万
  • 项目类别:
Targeting PLK1 in RAS mutant chronic myelomonocytic leukemia
RAS 突变型慢性粒单核细胞白血病中的靶向 PLK1
  • 批准号:
    10656778
  • 财政年份:
    2023
  • 资助金额:
    $ 101.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了